Want to join the conversation?
$BBRY posted a wider loss in 2Q17, hurt by lower revenues compared to 2Q16. Net loss was $372MM or $0.71 per diluted share compared to net income of $51MM and a loss per share of $0.24 last year. GAAP revenue fell about 32% from last year to $334MM, and non-GAAP revenue was $352MM in the quarter. The company reported breakeven non-GAAP EPS in 2Q17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?